Document is current
Any future updates will be listed below
-
Authors
Naveau, Adrien https://orcid.org/0000-0003-4199-0015
Kret, Marion
Plaire, Valérie
Delorme, Olivier
Marchi, Sébastien
de Bataille, Caroline
Destruhaut, Florent
Arrive, Elise
Bou, Christophe
-
Funding
Funding for this research was provided by:
Centre Hospitalier Universitaire de Bordeaux (CHUBX 2018/34)
- License Information
-
More Information
Article History
Received: 5 December 2020
Accepted: 8 March 2022
First Online: 18 March 2022
Declarations
:
: Written informed consent will be obtained from all study participants. The trial was approved by the French National Agency for Drug Safety (Agence Nationale de Sécurité du Medicament et Produits de Santé [ANSM] in March 2019) and by a French Ethics Committee for Person Protection (Comité de Protection des Personnes [CPP]; trial number 2018-A02658–47, in May 2019). The trial was registered on on July 4, 2019 (registration no. NCT04009811), and on the European base ID-RCB under the number 2018-A02658-47. The data confidentiality protocol has been approved by the National Committee of Informatics and Freedom (Comité National Informatique et Liberté; CNIL); patient names will not be recorded in the database.
: Not applicable.
: The authors declare that they have no competing interests.
